Anti-inflammatory therapy for atherosclerosis: interpreting divergent results from the CANTOS and CIRT clinical trials

J Intern Med. 2019 May;285(5):503-509. doi: 10.1111/joim.12862. Epub 2018 Dec 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Atherosclerosis / drug therapy*
  • Humans
  • Interleukin-1beta / antagonists & inhibitors*
  • Methotrexate / therapeutic use*
  • Randomized Controlled Trials as Topic

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Interleukin-1beta
  • canakinumab
  • Methotrexate